สำนักงานราชบัณฑิตยสภา

103 ใจนุช จงรั กษ์ วารสารราชบัณฑิตยสถาน ปีที่ ๓๘ ฉบับที่ ๓ ก.ค.-ก.ย. ๒๕๕๖ Starck W J, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report. Int J Oral Maxillofac Implants 1995: 10; 74-8. The American Dental Association Council on Scientific Affairs. Dental management of patients recieving oral bisphosphonate therapy, expert panel recommendation. JADA 2006, 137: 1144-50. Thorn, JJ, Hansen HS, Specht L and Bastbolt L. Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg 2000, 58: 1088-93. Tong CK, Ho ST, Wong SL. Osteonecrosis of the jaws after oral bisphosphonate for osteoporosis. Hong Kong Med J 2010: 16; 145-148. Treister N, Sheeby N, Bac EH, Friedland B, Lerman M, Woo S. Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws. Oral Disease. 2009: 15; 88-92. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg. 2003; 61: 1104-1107. Woo SB, Hellstien JW, Kalmar JR: Systemic review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006, 144; 753-761. Widmark G, Sagne S, Heikel P. Osteonecrosis of the jaws. Int J Oral Maxillofac. 1989: 18: 302-306. Wood J, Bonjean K, Ruetz A, Bellahcene L, Devy L, Foidart V, et al. Novel antiangiogenic effects of bisphosphonate compound Zoledronic acid. J Pharmacol Exp Ther, 2002 302; 1055-61.